Theranos: Page 5
Report: Theranos Lab Didn't Live Up to Its Own Accuracy Standards
Data confirms that the company knew its finger pin-prick tests were often wrong when it used them in October, 2014.
Theranos Is Dealt Another Blow, With 'Abnormal' Results In New Lab Study
The higher number of abnormal test results, researchers wrote, 'can have negative consequences for medicine in the form of extra testing, additional patient visits to clinics/hospitals, and added doctor services.'
Theranos May Have Run Blood Tests Despite Quality Issues
Eighty one patients in a six-month period received hematology results that were not adequately controlled for quality.
Walgreens Pumps the Brakes on Theranos Partnership Amid Problematic Lab Audit
After one of Theranos' labs was found to pose immediate jeopardy to patient safety, Walgreens has ordered that no blood tests be analyzed there.
Theranos Poses 'Immediate Jeopardy' to Patient Health, Government Says
The embattled blood-testing startup's lab practices were found to be deficient.
Report: Federal Regulators Find 'Serious Deficiencies' at Theranos' California Lab Facility
The findings could lead to Theranos' suspension from the Medicare program.
Health Regulators Are Investigating Theranos's Blood Test Technology
The investigations follow complaints filed by two former Theranos employees, casting even greater doubt upon the honesty and accuracy of the $9 billion blood test startup.
Safeway Seeks to Dissolve Secret $350 Million Deal With Beleaguered Blood Startup Theranos
The partnership, code-named project 'T-Rex,' called for Theranos blood test facilities to be built in 800 Safeway stores nationwide.
These Are the World's Top 10 Young Billionaires
Young, smart and filthy rich, these charmed tycoons have it all.
Theranos Founder Says the Company Will 'Absolutely' Get FDA Approval
Despite a recent barrage of bad press, the company's founder and CEO is confident in the company's future.
Theranos Restructures Board Amid Concerns About Its Technology
The blood testing startup has shrunk its board from 12 members to five, a move it says happened back in July.
Out For Blood: Theranos Orchestrates Bold PR Coup in the Face of Damning Allegations
The $9 billion blood-test startup is facing allegations that it's struggling with its ostensibly groundbreaking tech. But is it taking the right approach to responding to the crisis?